Seminars in Oncology
Volume 34, Supplement 5 , Pages S13-S20, December 2007

Three New Drugs for Acute Lymphoblastic Leukemia: Nelarabine, Clofarabine, and Forodesine

  • Richard A. Larson

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Richard A. Larson, MD, Section of Hematology/Oncology, The University of Chicago, 5841 S Maryland Ave, MC-2115, Chicago, IL 60637.
    • Dr Larson has served as a consultant to GlaxoSmithKline and BioCryst Pharmaceuticals.

Hematologic Malignancies Program, Section of Hematology/Oncology, Department of Medicine, Cancer Research Center, The University of Chicago, Chicago, IL.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00220-5

doi:10.1053/j.seminoncol.2007.11.002

Seminars in Oncology
Volume 34, Supplement 5 , Pages S13-S20, December 2007

Article Tools

* Image Usage & Resolution